Results
1 -
10 of
118Lissette R. Perez and Katherine J. Franz.
Minding metals: Tailoring multifunctional chelating agents for neurodegenerative disease, Dalton Trans., 2010, 39, 2177. Feng et al..
Small-molecule aggregates inhibit amyloid polymerization, Nature Chemical Biology, 2008 David E. Green, Meryn L. Bowen, Lauren E. Scott, Tim Storr, Michael Merkel, Karin Böhmerle, Katherine H. Thompson, Brian O. Patrick, Harvey J. Schugar and Chris Orvig.
In vitro studies of 3-hydroxy-4-pyridinones and their glycosylated derivatives as potential agents for Alzheimer's disease, Dalton Trans., 2010, 39, 1604. Chengke Wang, Jine Wang, Dianjun Liu and Zhenxin Wang.
Studying copper(ii) ion induced interactions of β-amyloidpeptides within living cells by gold nanoparticleprobes, Anal. Methods, 2010, 2, 1467. Robert C. Hider, Sourav Roy, Yong Min Ma, Xiao Le Kong and Jane Preston.
The potential application of iron chelators for the treatment of neurodegenerative diseases, Metallomics, 2011, 3, 239. Masahiro Kawahara, Hironari Koyama, Tetsuya Nagata and Yutaka Sadakane.
Zinc, copper, and carnosine attenuate neurotoxicity of prion fragment PrP106-126, Metallomics, 2011, 3, 726. Lauren E. Scott, Maria Telpoukhovskaia, Cristina Rodríguez-Rodríguez, Michael Merkel, Meryn L. Bowen, Brent D. G. Page, David E. Green, Tim Storr, Fancy Thomas, David D. Allen, Paul R. Lockman, Brian O. Patrick, Michael J. Adam and Chris Orvig.
N-Aryl-substituted 3-(β-D-glucopyranosyloxy)-2-methyl-4(1H)-pyridinones as agents for Alzheimer's therapy, Chem. Sci., 2011, 2, 642. Clioquinol Protects Against Cell Death in Parkinson?s Disease Models In Vivo and In Vitro, The Basal Ganglia IX